Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma.
Lipton A, Harvey HA, Lawrence B, Gottlieb R, Kukrika M, Dixon R, Graham W, Miller S, Heckard R, Schelzel D, White DS.
Lipton A, et al. Among authors: harvey ha.
Cancer. 1983 Jan 1;51(1):57-60. doi: 10.1002/1097-0142(19830101)51:1<57::aid-cncr2820510114>3.0.co;2-v.
Cancer. 1983.
PMID: 6821809
Clinical Trial.